March 30, 2021 – Roche Pharmaceuticals Suspends Huntington's Disease Trial

This disappointing result was unexpected based on preclinical studies undertaken by Ionis Pharmaceuticals who, along with the Center, has championed the use of antisense therapeutics for treating neurologic disorders. Click here for more information.

© 2021 by Center for Neurologic Study.